Lauren C Aguado

RNase III nucleases from diverse kingdoms serve as antiviral effectors

S. Cherry, D. Sachs, B. tenOever, 2017, Nature.

RNase III Nucleases and the Evolution of Antiviral Systems

B. tenOever, Lauren C Aguado, 2018, BioEssays : news and reviews in molecular, cellular and developmental biology.

Drosha as an interferon-independent antiviral factor

S. Cherry, D. Sachs, B. tenOever, 2014, Proceedings of the National Academy of Sciences.

Homologous recombination is an intrinsic defense against antiviral RNA interference

M. Vignuzzi, B. tenOever, Daniel Blanco-Melo, 2018, Proceedings of the National Academy of Sciences.

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

C. Rice, M. Nussenzweig, P. Bieniasz, 2021, Nature.

Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.

C. Rice, M. Nussenzweig, P. Bieniasz, 2021, bioRxiv : the preprint server for biology.

Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis

Florian Krammer, Matthew S. Miller, Domenico Tortorella, 2013, Science Translational Medicine.

microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection.

D. Sachs, B. tenOever, Jean K. Lim, 2015, Cell host & microbe.

RNA virus building blocks—miRNAs not included

B. tenOever, Lauren C Aguado, 2018, PLoS pathogens.